In this Viewpoint, Elliott Fisher and colleagues review the emerging field of implementation science as a framework for planning innovations in health care delivery.
This Viewpoint discusses the clinical performance of aging physicians as a factor in the larger question of how best to evaluate physician competency.
This Viewpoint discusses the potential influence of precision medicine that incorporates epigenetic analysis in effectively treating hypertension.
This randomized clinical trial compares the effects of vitamin D3 supplementation vs placebo during women’s third trimester of pregnancy on age at onset of persistent wheeze in the children in the first 3 years of life.
This randomized clinical trial assesses whether high-dose vitamin D supplementation during the third trimester of women at high risk of having children with asthma reduces asthma or recurrent wheeze in their offspring.
This randomized trial compares the efficacy of varenicline, nicotine patch, and combination nicotine replacement therapy (patch plus lozenges) on smoking abstinence at 26 weeks among adults interested in quitting smoking.
This Recommendation Statement from the US Preventive Services Task Force recommends screening for depression in the general adult population, including pregnant and postpartum women, with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.
This systematic review to support the 2016 US Preventive Services Task Force Recommendation Statement on screening for depression summarizes trial evidence about depression screening, treatment, and accuracy of screening instruments in pregnant and postpartum women.
This Guide to Statistics and Methods discusses analyzing repeated measurements using mixed models.
This Clinical Evidence Synopsis summarizes a Cochrane review on the efficacy of immunotherapies for multiple sclerosis.
This study uses data collected between April 2010 and April 2013 to assess the safety of propranolol for severe infantile hemangioma in children given this therapy under the French Health Products Agency compassionate use program.
This Medical News and Perspectives article discusses advances in 3-D printing that are being used to solve unique clinical challenges.